Fig. 2From: Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of 18F-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-AgIn male patients with NSCLC, the area under the receiver operating characteristic curve (AUC) for individual factors was calculated to predict EGFR mutation status. A SUVmax of the primary lesions. B Serum concentration of CYFRA21-1. C Serum concentration of SCC-AgBack to article page